The Prokinetic Shortlist: What Actually Has Human Trial Data

Last week we promised to tackle prokinetics — the products that claim to make your gut move faster. We pulled the human trial data on every popular option in the supplement aisle, and the results are exactly what you'd expect from this newsletter: most of what's on the shelf is hope, not evidence. But there is a small short list of products with real published RCTs behind them, and one prescription option your gastroenterologist almost certainly hasn't mentioned.

Here's the honest map of the prokinetic landscape, sorted by how much evidence actually exists for each option.

What "prokinetic" actually means (and why it's not a laxative)

A prokinetic doesn't pull water into your gut the way magnesium citrate or MiraLAX does. It works upstream — by stimulating the migrating motor complex, the wave-like contraction pattern that sweeps your small intestine clean between meals. When that pattern is sluggish, food sits, bloating builds, and the entire downstream timeline shifts. By the time stool reaches the colon, it's already too dehydrated and too delayed.

This matters because the most common mistake we see in the inbox is people stacking laxatives on top of an upstream motility problem. They take more magnesium, more fiber, more prunes — and nothing changes, because the bottleneck isn't water in the colon, it's transit speed in the small bowel. A prokinetic is the right tool when:

• You feel "full" two hours after a normal meal more days than not
• Bloating peaks in the late afternoon or evening, not after a specific food
• Your magnesium and fiber are dialed in but your bowel pattern is still erratic
• You've been told you have "slow transit" or suspected SIBO

If your problem is acute constipation right now, this is the wrong week's brief — go back to Edition 002 and the osmotic options there.

Tier 1: The one supplement with real human trial data

The strongest evidence in the natural-prokinetic category sits with one specific combination: a standardized extract of artichoke leaf and ginger, sometimes sold under the trade name Prodigest. It has been studied in randomized, placebo-controlled human trials — most notably a 2015 trial in functional dyspepsia (n=126, four weeks) and a 2016 pilot in gastric emptying. Both showed statistically significant improvement in upper-GI motility versus placebo.

Two important caveats before you click buy. First, almost all of the published data is for functional dyspepsia (chronic indigestion), not chronic constipation specifically. The mechanism — accelerated gastric emptying and small-bowel transit — is plausibly relevant to slow-transit constipation, but the direct constipation evidence is thinner than the marketing suggests. Second, this is a slow-acting supplement. Run it for a full six to eight weeks before judging it. People who quit at week two and write angry reviews are operating on a laxative timeline; this is a motility-pattern timeline.

is the version we recommend — it's the same standardized formulation studied in the trials, in a practitioner-grade capsule, at the dose used in the literature.

Tier 2: The European herbal that's been quietly working for forty years

Iberogast is a nine-herb liquid extract that has been sold over-the-counter in German pharmacies for nearly four decades. It includes bitter candytuft, peppermint, caraway, lemon balm, chamomile, and several others, and it's been studied in multiple double-blind trials, mostly in functional dyspepsia and IBS-mixed presentations. The mechanism is partly through bitter receptors that stimulate the upper GI tract, and partly through smooth-muscle modulation in the small bowel.

It is bitter — that is genuinely the point. The dose is twenty drops in a small glass of water before each meal. Most readers tolerate it fine after a week of getting used to the taste. A meaningful subset find it more useful than capsule prokinetics because the liquid format gets working within twenty to thirty minutes rather than hours.

became available in the US a few years ago. One important caution: it contains celandine, which is contraindicated if you have liver disease or take medications metabolized heavily by the liver. Talk to your doctor or pharmacist before starting if you're on any chronic prescription.

Tier 3: Ginger alone — yes, kind of, but not the way you think

Plain ginger root capsules will show up in any prokinetic search, and they do have some evidence — but mostly for nausea and gastric emptying, not bowel transit. A few small studies have shown that 1.2g of ginger before a meal can speed gastric emptying by about 25%. That's a real effect. It's just not a gut-motility effect in the way most readers want.

If you already have ginger capsules in your cabinet and you're getting some benefit, keep using them — they're cheap and safe. But if you're shopping new, the standardized ginger-plus-artichoke combination above gives you the same ginger benefit plus the artichoke leaf's bile-flow effect, which appears to add meaningfully to the prokinetic action. Buying ginger capsules separately is a good budget move; expecting them to fix a slow-transit picture on their own usually disappoints.

Tier 4: The prescription option no one talks about

If you've optimized magnesium, run a real prokinetic for eight weeks, and your transit is still abnormally slow, the next conversation is with a gastroenterologist about prucalopride (sold as Motegrity in the US). It's a selective 5-HT4 serotonin agonist that directly stimulates colonic motility. The pivotal trial was published in the New England Journal of Medicine in 2008 and showed clear improvement in bowel function over twelve weeks for patients with severe chronic constipation that hadn't responded to laxatives.

We're mentioning it not because we're recommending you go straight to prescription, but because most readers have never heard of it. Many gastroenterologists default to recommending more fiber or more polyethylene glycol because that's what the patient education handouts say. Prucalopride is FDA-approved specifically for chronic idiopathic constipation in adults, it's covered by most insurance with a prior authorization, and the side-effect profile in trials was mild (mostly headache and brief nausea in week one). If you've been stuck for years, it's worth asking your GI specifically about it.

What to skip

A few products that show up at the top of every prokinetic search and don't have the data to back the marketing:

• Senna and cascara, which are stimulant laxatives, not prokinetics. They work the colon, not the upstream motor pattern, and they cause dependence with daily use. Acceptable for an occasional acute episode, not as a long-term tool.
• "Motility blends" from supplement brands you've never heard of, which usually combine a tiny dose of ginger with a long list of herbs at sub-therapeutic doses. Read the label — if the active ingredients are listed without milligram amounts, walk away.
• Magnesium glycinate "for motility," because as we covered in Edition 004, glycinate is fully absorbed in the small intestine and has zero effect on bowel transit. Whoever is marketing it that way is hoping you don't read.

This week's protocol

If you've already optimized magnesium (Edition 001 and 004) and ruled out a pelvic floor problem (Edition 002), and you're still dealing with slow transit or post-meal bloating, here's the order to try:

The first move is eight weeks of

at one capsule before lunch and one before dinner. Eight weeks is the unit of judgment, not eight days. Keep your magnesium running underneath it; the two work on different parts of the GI tract and don't compete.

If after eight weeks you're seeing real improvement, stay on it for a six-month run and then taper. If you're seeing nothing, the next move is either to swap to

for a four-week trial — different mechanism, faster onset, often catches the people who don't respond to capsule prokinetics — or to escalate the conversation with your gastroenterologist about prucalopride.

If you've done all of the above and you're still stuck, the bottleneck is probably not motility at all. That's the signal to push for a transit study (a five-day capsule study that actually measures how long things take through your gut) and a colonic manometry referral if the transit study is abnormal. Those tests are how you separate "this is a supplement problem" from "this is a structural problem that needs a different specialist."

Next week we're doing something readers have been asking for since Edition 001: a real, evidence-based look at fiber. The right kind, the right dose, the timing that matters, and why the standard "30 grams a day" advice is probably making half of you worse, not better.

— The Bowel Brief Team

Some links in this edition are affiliate links to products we've personally evaluated. If you buy through them, we earn a small commission at no extra cost to you. Editorial recommendations are independent of these relationships — see our products page for the full disclosure.